NCT01267500

Brief Summary

Non-surgical treatment (ie. patching or fusion exercises) of intermittent exotropia may help in increasing control of strabismus

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 27, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 28, 2010

Completed
6.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2017

Completed
Last Updated

March 20, 2023

Status Verified

March 1, 2023

Enrollment Period

7 years

First QC Date

December 27, 2010

Last Update Submit

March 15, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Control of strabismus

    1 year

Study Arms (1)

Non-surgical therapy

EXPERIMENTAL

patching or fusion exercises

Procedure: Non surgical therapy

Interventions

patching or fusion exercises

Non-surgical therapy

Eligibility Criteria

Age3 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Age 3 to 12 years (inclusive)
  • IXT for distance or constant IXT for distance and either IXT or exophoria for near
  • IXT size of \> 10PD
  • Visual acuity in worse eye of at least 0.3 logMar (Snellen 6/12)
  • Visual acuity of no greater than 2 lines between eyes
  • Parents or guardian willing to accept randomization, and to continue with observation or treatment for at least 6-12 months, unless deterioration of strabismus or fall in best corrected visual acuity of worse than 0.3logMar (Snellen 6/12) in either eye
  • Investigator willing to observe IXT untreated for at least 1 year

You may not qualify if:

  • Previous non-surgical treatment for IXT, or patch treatment for amblyopia within the last year
  • Prior strabismus, intraocular or refractive surgery or botulinium injection
  • Surgery planned within the next year
  • Prematurity (birth weight \< 1500g, gestational age \< 34 weeks), systemic illness (eg. cerebral palsy), syndrome (including craniosynostosis) or learning disability
  • Any ocular abnormality (cornea, lens or central retina); nystagmus or conditions that limit eye movements.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SIngapore National Eye Centre

Singapore, Singapore

Location

Study Officials

  • audrey chia

    Singapore National Eye Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Consultant

Study Record Dates

First Submitted

December 27, 2010

First Posted

December 28, 2010

Study Start

October 1, 2010

Primary Completion

October 1, 2017

Study Completion

October 1, 2017

Last Updated

March 20, 2023

Record last verified: 2023-03

Locations